Table 3.
Dissolution test results of artemether–lumefantrine samples (N = 74) collected from low and high malaria transmission settings in Uganda, June–December 2021
| Brand name | Artemether label claim (mg) | Number of samples tested n (%) |
Artemether within pharmacopeial limit, 70% Pass/Fail |
Lumefantrine within pharmacopeial limit, 60% Pass/Fail |
|---|---|---|---|---|
| LONART | 20/120 | 20 (27%) | Pass | Pass |
| 40/240 | 1 (1.4%) | Pass | Pass | |
| 80/480 | 3 (4.1%) | Pass | Pass | |
| LONART-DS | 80/480 | 1 (1.4%) | Pass | Pass |
| ARTEFAN | 20/120 | 12 (16.2%) | Pass | Pass |
| 40/240 | 1 (1.4%) | Pass | Pass | |
| 60/360 | 1(1.4%) | Pass | Pass | |
| 80/480 | 1(1.4%) | Pass | Pass | |
| LUMARTEM | 20/120 | 2 (2.7%) | Pass | Pass |
| 80/480 | 1 (1.4%) | Pass | Pass | |
| CO-METHER | 20/120 | 5 (6.8%) | Pass | Pass |
| KOMEFAN-140 | 20/120 | 1 (1.4%) | Pass | Pass |
| COMBIART | 20/120 | 5 (6.8%) | Pass | Pass |
| LUMERAX | 20/120 | 1 (1.4%) | Pass | Pass |
| LARIACT | 20/120 | 3 (4.1%) | Pass | Pass |
| Cach-ART | 20/120 | 2 (2.7%) | Pass | Pass |
| LUMAREN | 20/120 | 2 (2.7%) | Pass | Pass |
| COARTEM | 20/120 | 1 (1.4%) | Pass | Pass |
| KOMEFAN | 20/120 | 1 (1.4%) | Pass | Pass |
| LUMITER | 20/120 | 6 (8.1%) | Pass | Pass |
| Not Indicateda | 20/120 | 4 (5.4%) | Pass | Pass |
| Total number | 74 (100%) | 74 (100%) | 74(100%) | |
aOne batch of samples with not brand name indicate (HWE111219) from a low malaria transmission setting had 68% artemether dissolution